Skip navigation

Integrate Novel Technologies, Strategies and Cross-Functional Approaches to Accelerate Development and Compress Timelines

October 19-20, 2017
  • San Francisco, CA

Sid Advant, PhD
Executive Director, Biologics Manufacturing
Celgene

Martin J. Allen, PhD
Senior Director, Cell Line Development,
BioProcess Research and Development
Pfizer Inc

Fredrik Åsell, MSc
Head of Quality, Supply Americas
AstraZeneca

Nicole Bleckwenn, PhD
Associate Director, Bioprocess Engineering
MedImmune

Denis Boyle, PhD
Consultant
BioProcess Technology Consultants

Jill M. Carton, PhD
Director, Biologics Research, Janssen BioTherapeutics
Janssen R&D

Jon Coffman, PhD
Global Head, Innovation and Technology, Biopharma
Boehringer Ingelheim Fremont, Inc.

Jessica Dawson
Associate Director, Analytical Development, Protein and Cell Sciences
EMD Serono Research and Development Institute

Lianchun Fan, PhD
Principal Scientist and Group Leader, Bioprocess Development
Bristol-Myers Squibb

Stephen Farrand, PhD
Chief Technology Officer
Jounce Therapeutics

Igor Fisch, PhD
CEO and Chairman
Selexis, Switzerland

Nuno Fontes, PhD
Executive Director, Site Head of Process Science
Boehringer Ingelheim Fremont, Inc.

Bert Frohlich, PhD
Principal Consultant Engineer
Biopharm Services

Subinay Ganguly, PhD
Senior Scientific Director, Cell and Developability Sciences,
Pharmaceutical Development and Manufacturing Sciences
Janssen Research & Development, LLC

Uwe Gottschalk, PhD
Chief Technology Officer
Lonza, Switzerland

Susan Dana Jones, PhD
Vice President and Principal Consultant
BPTC

Thomas Jostock, PhD
Group Head, Cell Line Development
Novartis, Switzerland

Kenneth Kang, PhD
Director, Process Development
Patheon

Daniel Kita, PhD
Development Scientist I, Early Stage Process Development
Alexion Pharmaceuticals, Inc.

Uma Kuchibhotla, PhD
Chief Scientific Officer, Lead Optimization
Eli Lilly and Company

Peter Latham
President
Latham Biopharm Group

Huong Le, PhD
Scientist, Drug Substance Technologies, Process Development
Amgen, Inc.

Gene W. Lee, PhD
Senior Director, Protein and Cell Sciences
EMD Serono

Padma Malyala, PhD
Drug Product Strategy/Biologics Expert,
Technical Development-Novel Biologic Entities,
Integrated Biologics Profiling, Portfolio Management
Novartis Institutes for BioMedical Research, Inc.

Sigma Mostafa, PhD
Vice Prevent, Process Development
KBI Biopharma

Michael F. Naso, PhD
Director, Biologics Research
Janssen Research & Development, LLC

Domingos Ng, MEng
Principal Research Associate
Genentech, Inc.

Yashas Rajendra, PhD
Senior Research Scientist, Biotechnology Discovery Research, Protein Expression
Eli Lilly and Company

Natraj Ram, PhD
Associate Director, Purification, Manufacturing Sciences
AbbVie

Pranhitha Reddy, PhD
Founder
Gene to BLA Consulting, LLC

Mark Rice, PhD
Director, Upstream Process Development
CMC Biologics

Cleo Salisbury, PhD
Group Leader, Technical Development Senior Scientist
Genentech, Inc.

Kristi Sarno
Senior Consultant
Latham Biopharm Services

Amy Shen, PhD
Senior Scientist and Group Leader, Early Stage Cell Culture
Genentech, Inc.

Abhinav Shukla, PhD
Senior Vice President, Process Development and Manufacturing
KBI Biopharma

Jim Thomas, PhD
President and CEO
Just Biotherapeutics, Inc.

Kim Wolfram, MS
Director, Protein Team Lead, Regulatory CMC
Biogen

Matthew Wollerton, PhD, PMP
Associate Director, CMC Project Management, Pipeline Management
MedImmune

Greg Zarbis-Papastoitsis, PhD
Vice President, Process and Manufacturing
Compass Therapeutics

Sid Advant, PhD
Executive Director, Biologics Manufacturing
Celgene

Martin J. Allen, PhD
Senior Director, Cell Line Development,
BioProcess Research and Development
Pfizer Inc

Fredrik Åsell, MSc
Head of Quality, Supply Americas
AstraZeneca

Nicole Bleckwenn, PhD
Associate Director, Bioprocess Engineering
MedImmune

Denis Boyle, PhD
Consultant
BioProcess Technology Consultants

Jill M. Carton, PhD
Director, Biologics Research, Janssen BioTherapeutics
Janssen R&D

Jon Coffman, PhD
Global Head, Innovation and Technology, Biopharma
Boehringer Ingelheim Fremont, Inc.

Jessica Dawson
Associate Director, Analytical Development, Protein and Cell Sciences
EMD Serono Research and Development Institute

Lianchun Fan, PhD
Principal Scientist and Group Leader, Bioprocess Development
Bristol-Myers Squibb

Stephen Farrand, PhD
Chief Technology Officer
Jounce Therapeutics

Igor Fisch, PhD
CEO and Chairman
Selexis, Switzerland

Nuno Fontes, PhD
Executive Director, Site Head of Process Science
Boehringer Ingelheim Fremont, Inc.

Bert Frohlich, PhD
Principal Consultant Engineer
Biopharm Services

Subinay Ganguly, PhD
Senior Scientific Director, Cell and Developability Sciences,
Pharmaceutical Development and Manufacturing Sciences
Janssen Research & Development, LLC

Uwe Gottschalk, PhD
Chief Technology Officer
Lonza, Switzerland

Susan Dana Jones, PhD
Vice President and Principal Consultant
BPTC

Thomas Jostock, PhD
Group Head, Cell Line Development
Novartis, Switzerland

Kenneth Kang, PhD
Director, Process Development
Patheon

Daniel Kita, PhD
Development Scientist I, Early Stage Process Development
Alexion Pharmaceuticals, Inc.

Uma Kuchibhotla, PhD
Chief Scientific Officer, Lead Optimization
Eli Lilly and Company

Peter Latham
President
Latham Biopharm Group

Huong Le, PhD
Scientist, Drug Substance Technologies, Process Development
Amgen, Inc.

Gene W. Lee, PhD
Senior Director, Protein and Cell Sciences
EMD Serono

Padma Malyala, PhD
Drug Product Strategy/Biologics Expert,
Technical Development-Novel Biologic Entities,
Integrated Biologics Profiling, Portfolio Management
Novartis Institutes for BioMedical Research, Inc.

Sigma Mostafa, PhD
Vice Prevent, Process Development
KBI Biopharma

Michael F. Naso, PhD
Director, Biologics Research
Janssen Research & Development, LLC

Domingos Ng, MEng
Principal Research Associate
Genentech, Inc.

Yashas Rajendra, PhD
Senior Research Scientist, Biotechnology Discovery Research, Protein Expression
Eli Lilly and Company

Natraj Ram, PhD
Associate Director, Purification, Manufacturing Sciences
AbbVie

Pranhitha Reddy, PhD
Founder
Gene to BLA Consulting, LLC

Mark Rice, PhD
Director, Upstream Process Development
CMC Biologics

Cleo Salisbury, PhD
Group Leader, Technical Development Senior Scientist
Genentech, Inc.

Kristi Sarno
Senior Consultant
Latham Biopharm Services

Amy Shen, PhD
Senior Scientist and Group Leader, Early Stage Cell Culture
Genentech, Inc.

Abhinav Shukla, PhD
Senior Vice President, Process Development and Manufacturing
KBI Biopharma

Jim Thomas, PhD
President and CEO
Just Biotherapeutics, Inc.

Kim Wolfram, MS
Director, Protein Team Lead, Regulatory CMC
Biogen

Matthew Wollerton, PhD, PMP
Associate Director, CMC Project Management, Pipeline Management
MedImmune

Greg Zarbis-Papastoitsis, PhD
Vice President, Process and Manufacturing
Compass Therapeutics